Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Sanofi SA    SNY

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Sanofi SA
Engages in the research, production and distribution of pharmaceutical products

Sanofi engages in the research, production and distribution of pharmaceutical products.

It operates through the following business segments: Pharmaceuticals, Human Vaccines, and Animal Health.

The Pharmaceuticals segment includes research, development, production and sales activities relating to pharmaceutical products, including prescription, consumer health care, and generic products.

This segment also includes equity affiliates and joint ventures with pharmaceutical business activities.

The Human Vaccines segment includes research, development, production and marketing of vaccines.

The Animal Health segment comprises the research, development, production and marketing activities for Merial, which offers a range of medicines and vaccines for animal species.

The company was founded on April 28, 1994 and is headquartered in Paris, France.

Number of employees : 106 859 persons.
Sales per Businesses
20152016Delta
USD (in Million)%USD (in Million)%
Pharmaceuticals32,88886.3%32,27986.5% -1.85%
Vaccines5,23513.7%5,05213.5% -3.49%
Sales per Regions
20152016Delta
USD (in Million)%USD (in Million)%
United States13,51535.5%13,67736.6% +1.19%
Western Europe5,79215.2%---
Asia (Excluding Pacific Region)3,90310.2%---
Latin America3,3638.8%2,7637.4% -17.85%
Eastern Europe and Turkey2,6116.8%---
France2,4816.5%2,4356.5% -1.86%
Africa and Middle-East2,4526.4%---
Japan2,2455.9%1,8635% -17%
Other920.452.4%771.542.1% -16.18%
Rest of the World839.892.2%991.192.7% +18.01%
Europe--7,14519.1%-
Asia (Excluding South Asia)--3,4329.2%-
Africa, Middle East and South Asia--3,0518.2%-
Eurasia--1,2033.2%-
Managers
NameAgeSinceTitle
Olivier Brandicourt MD, PhD612015Chief Executive Officer & Director
Serge Weinberg662009Chairman
Jérôme Contamine602009Chief Financial Officer & EVP-Finance
Elias A. Zerhouni, MD662011President-Global Research & Development
Yong-Jun Liu MD, PhD-2016Head-Global Research & Development
Ameet Nathwani MD, MBA502016Executive Vice President-Medical Affairs
Robert Castaigne, PhD712000Independent Director
Claudie Haigneré MD, PhD602008Independent Director
Carole Piwnica592010Independent Director
Suet-Fern Lee592011Independent Director
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Share A 1 1,292,022,324 1,103,109,372 85.4% 20,084,045 1.6% 85.4%
Shareholders
NameEquities%
Dodge & Cox 67,977,413 2.63%
Barrow, Hanley, Mewhinney & Strauss LLC 29,418,481 1.14%
Franklin Advisers, Inc. 20,688,292 0.80%
Fisher Asset Management LLC 12,615,505 0.49%
Hotchkis & Wiley Capital Management LLC 10,364,345 0.40%
Boston Partners Global Investors, Inc. 8,527,002 0.33%
Invesco Advisers, Inc. 7,418,466 0.29%
Federated Investment Management Co. 5,123,688 0.20%
Managed Account Advisors LLC 4,511,907 0.17%
Fidelity Management & Research Co. 4,291,821 0.17%
Holdings
NameEquities%Valuation
Regeneron Pharmaceuticals Inc (REGN) 23,505,69422.6%9,131,727,062 USD
Sanofi (SAN) 20,084,0451.55%1,894,205,817 USD
Aventis Pharma Limited (AVPH) 13,909,58760.4%908,782,728 USD
Alnylam Pharmaceuticals, Inc. (ALNY) 10,256,63311.9%549,755,529 USD
Zentiva SA (ROSCD) 312,341,64974.9%167,221,472 USD
JHL Biotech Inc (6540) 28,415,11112.9%56,979,117 USD
Myokardia Inc (MYOK) 3,668,89911.7%47,879,132 USD
Voyager Therapeutics Inc (VYGR) 2,477,9419.23%25,869,704 USD
Regulus Therapeutics Inc (RGLS) 5,053,7799.55%7,833,357 USD
SCYNEXIS Inc (SCYX) 1,677,0576.55%4,662,218 USD
Sector
Healthcare
Pharmaceuticals & Medical Research
 Pharmaceuticals
  Pharmaceuticals
   Pharmaceuticals - NEC
Advertisement
Sector Pharmaceuticals - NEC
1st jan.Capitalization (M$)
SANOFI SA21.24%123 549
JOHNSON & JOHNSON10.69%341 901
ROCHE HOLDING LTD.14.88%236 581
NOVARTIS AG6.75%211 457
PFIZER INC.-1.05%191 398
MERCK & CO., INC.10.28%177 567
SANOFI13.54%123 549
BAYER AG18.68%107 863
GLAXOSMITHKLINE PLC3.59%103 436
BRISTOL-MYERS SQUIBB C..-6.93%88 912
ELI LILLY AND CO6.12%86 117
ASTRAZENECA PLC17.39%85 598
NOVO NORDISK A/S8.76%81 904
ABBOTT LABORATORIES14.42%77 584
ALLERGAN PLC6.83%74 939
SHIRE PLC1.15%54 596
TAKEDA PHARMACEUTICAL ..19.28%40 927
TEVA PHARMACEUTICAL IN..-25.38%29 254
ASTELLAS PHARMA INC-13.28%27 253
MYLAN NV4.12%21 289
CHUGAI PHARMACEUTICAL ..25.48%21 152
Sector Pharmaceuticals - NEC
Sanofi SA : Connections
Piasa SA
Académie des Technologies
Madrigall SA
Fondation C.Génial
Financière Piasa SAS
Piasa Holding SAS
New York State Bar Association
Council on Foreign Relations, Inc.
Total Upstream UK Ltd.
Sanofi-Aventis Europe SAS
Fondation pour l’Université de Lyon
Sanofi-Aventis Participations SA
Financière Climater SAS
Maremma SASU
Rickmers Trust Management Pte Ltd.
Stamford Law Corp.
Sanofi-Aventis U.S. LLC
Pharmaceutical Research & Manufacturers of America
Weinberg Capital Partners SAS
Sanofi Pasteur Holding SA
National Committee on United States-China Relations, Inc.
Sanofi Pasteur Holding Ltd.
Omnium Insurance & Reinsurance Co. Ltd.
Fondation Lacoste
Academie de l'air et de l'espace
L'Oréal Corporate Foundation
Naxos UK Ltd.
Academie des Sports
Research!America
Académie des Sciences et Technologies
King Abdullah University of Science & Technology
i2O Water Ltd.
Warp Drive Bio LLC
Elevance Renewable Sciences, Inc.
Select Music & Video Distribution Ltd.
Académie Nationale de Médecine
National Academy of Engineering
Big Red, Inc.
Institute of Medicine
NAXOS Capital Managers SARL
The Johns Hopkins University
Morgan Lewis Stamford LLC
AXA Group Solutions
International Federation of Pharmaceutical Manufacturers A
Nanyang Technological University
International Bar Association
Stamford Corporate Services Pte Ltd.
World Justice Project
AXA Asia SAS
The Children's Aid Society, Inc.
Singapore Bar
Total Gestion Filiales
Singapore Academy of Law
Company contact information
Sanofi
54, rue La Boétie
Paris, Ile-de-France 75008

Phone : +33.1.53.77.40.00
Fax : +33.1.53.77.44.63
Web : www.sanofi.com
© 2017 People , Fundamentals and Ownership